The Market opens green this morning… stimulus talks are still in talk Veeva Systems rises three more percent to $303! Continuing on the healthcare stock success, we have another stock we believe you should be eyeing. NeoGenomics, Inc. only has a market cap of $4.4B and has recently become profitable. They operate a network of cancer-focused testing laboratories in the U.S., as well as labs in Switzerland and Singapore. They operate two segments … 1) Clinical Services and 2) Pharma Services. The company’s labs provide genetics and molecular testing services to hospitals, pathologists, oncologists, and other clinicians and researchers. In English, they provide cancer-focused laboratory testing sites to pharma companies, and this is extremely vital right now. It’s a name to keep in your back pocket… trading around $40/share right now.. we’ll have more on NeoGenomics soon. | 
